Gabelli Funds’s PDL BioPharma, Inc. PDLI Stock Holding History

Gabelli Funds’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-512,534	Closed	-$1.27M	–	1469
2020 Q4	$1.27M	Buy	+512,534	New	+$1.25M	0.01%	826

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Gabelli Funds's PDLI Position: Q1 2021 in Review

Gabelli Funds sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 512,534 shares — an estimated $1.27M sold.

Gabelli Funds first reported a position in PDLI in Q4 2020 and held it in 1 quarter. The position peaked at $1.27M in Q4 2020. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

Gabelli Funds reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
Gabelli Funds sold 512,534 PDL BioPharma, Inc. shares in Q1 2021, an estimated $1.27M.
Gabelli Funds first reported a position in PDL BioPharma, Inc. in Q4 2020 and held it in 1 quarter.
Gabelli Funds's PDL BioPharma, Inc. position peaked at $1.27M in Q4 2020.
11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.